Chris Gibson, the CEO of Utah-based techbio company Recursion, is stepping down after 12 years at the helm. Effective January 1, 2024, Najat Khan, the current...
California is set to introduce affordable insulin under its own brand starting on January 1, 2024, as part of a broader initiative to lower prescription drug...